Triantafyllos Chavakis

Triantafyllos Chavakis is a W3-Professor and Director of the Institute for Clinical Chemistry and Laboratory Medicine at University Clinic Carl Gustav Carus, Technische Universität Dresden, where he has led research since 2017. His career includes significant roles as Principal Investigator at the National Institutes of Health (NIH) and progressive academic appointments at TU Dresden. He holds a Dr. med from Justus-Liebig-Universität Gießen.

His research specializes in:

• Innate Immunity & Immunometabolism: Mechanisms of chronic inflammation in metabolic disorders (diabetes, NAFLD), cancer, and bone loss
• Leukocyte Biology: Adhesive interactions, recruitment, and resolution pathways (e.g., DEL-1 protein function)
• Systemic Crosstalk: Inflammation-metabolism interactions influencing myelopoiesis and trained immunity
• Cellular Dynamics: Regulation of hematopoietic progenitor cells and macrophage efferocytosis

Recent publications (2017-2022) demonstrate consistent focus on immunometabolic pathways across diseases, employing advanced techniques including multi-omics, epigenetic analyses, and in vivo disease modeling. His work frequently appears in top-tier journals like Cell and Nature Immunology.

He leads a research group at TU Dresden's University Clinic with expertise spanning molecular biology, advanced imaging, and systems immunology approaches. Current projects investigate inflammation resolution mechanisms and metabolic reprogramming of immune cells.